Forskning innen immunolgi og influensa. Kliniske studier med voksne og barn, vaksine studier og studier på innlagte pasienter med influensa sykdom.

Vitenskapelig artikkel

• Nabil Belbachir; Rebecca Jane Cox Brokstad; Julio Hernández et al. (2026). A Clinical Hygiene Ruler on the Basis of Hyperspectral Imaging and Machine Learning: A Proof-of-Concept Model for SARS-CoV-2 Virus Detection. (ekstern lenke)
• Irina Meln; Victor Cnossen; Nicoletta Corti et al. (2025). Regulatory workshop on standardisation of clinical procedures, endpoints and data robustness of human challenge studies – A stakeholder meeting report. (ekstern lenke)
• Kristin Greve-Isdahl Mohn; Birger Norderud Lærum; Steinar Skrede et al. (2013). Reduced Hospital Stay in Influenza Patients after Mass Vaccination during the 2009 Influenza Pandemic in Norway. (ekstern lenke)
• Nina Urke Ertesvåg; Rebecca Jane Cox; Sarah Larteley Lartey Jalloh et al. (2022). Seasonal influenza vaccination expands hemagglutinin-specific antibody breadth to older and future A/H3N2 viruses. (ekstern lenke)
• Hans-Kittil Viermyr; Bente Halvorsen; Ellen Lund Sagen et al. (2024). High viral loads combined with inflammatory markers predict disease severity in hospitalized COVID-19 patients: Results from the NOR-Solidarity trial. (ekstern lenke)
• Valeria Napolitano; Agnieszka Dabrowska; Kenji Schorpp et al. (2022). Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses. (ekstern lenke)
• Sudhir Venkatesan; Puja R. Myles; Kirsty J. Bolton et al. (2020). Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection. (ekstern lenke)
• Alessandro Manenti; Sarah Tete; Kristin Greve Isdahl Mohn et al. (2016). Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination. (ekstern lenke)
• Lena Hansen; Karl Albert Brokstad; Amit Bansal et al. (2023). Durable immune responses after BNT162b2 vaccination in home-dwelling old adults. (ekstern lenke)
• John Mair-Jenkins; Maria Saavedra-Campos; J. Kenneth Baillie et al. (2015). The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: A systematic review and exploratory meta-analysis. (ekstern lenke)
• Trine Kåsine; Anne Margarita Dyrhol Riise; Andreas Barratt-Due et al. (2021). Neutrophil count predicts outcome in hospitalized COVID-19 patients. Results from the NOR-Solidarity trial. (ekstern lenke)
• Gemma Pidelaserra Marti; Kristin Greve Isdahl Mohn; Rebecca Jane Cox et al. (2014). The Influence of Tonsillectomy on Total Serum Antibody Levels. (ekstern lenke)
• Nina Urke Ertesvåg; Julie Xiao; Fan Zhou et al. (2022). A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concern. (ekstern lenke)
• Anette Susanne Bøe Wolff; Lena Hansen; Marianne Aardal Grytaas et al. (2023). Vaccination prevents severe COVID-19 outcome in patients with neutralizing type 1 interferon autoantibodies. (ekstern lenke)
• Heidi Syre; Marius Eduardo Brå Obreque; Ingvild Dalen et al. (2022). The performances of three commercially available assays for the detection of SARS‐CoV‐2 antibodies at different time points following SARS‐CoV‐2 infection. (ekstern lenke)
• Elisabeth Berg Fjelltveit; Rebecca Jane Cox Brokstad; Jørgen Østensjø et al. (2020). Point-of-care influenza testing impacts clinical decision, patient flow and length of stay in hospitalized adults. (ekstern lenke)
• Therese Bredholt Onyango; Fan Zhou; Geir Bredholt et al. (2023). SARS-CoV-2 specific immune responses in overweight and obese COVID-19 patients. (ekstern lenke)
• Kristin Greve Isdahl Mohn; Rebecca Jane Cox; Gro Tunheim et al. (2015). Immune responses in acute and convalescent patients with mild, moderate and severe disease during the 2009 influenza pandemic in Norway. (ekstern lenke)
• Nina Urke Ertesvåg; Arild Iversen; Bjørn Blomberg et al. (2023). Post COVID-19 condition after delta infection and omicron reinfection in children and adolescents. (ekstern lenke)
• Geir Bredholt; Marianne Sævik; Hanne Søyland et al. (2024). Three doses of Sars-CoV-2 mRNA vaccine in older adults result in similar antibody responses but reduced cellular cytokine responses relative to younger adults. (ekstern lenke)
• Mai Chi Trieu; Amit Bansal; Anders Madsen et al. (2020). SARS-CoV-2-specific neutralizing antibody responses in Norwegian healthcare workers after the first wave of COVID-19 pandemic: a prospective cohort study. (ekstern lenke)
• Jack Alwin Panapasa; Rebecca Jane Cox; Kristin Greve Isdahl Mohn et al. (2015). The expression of B & T cell activation markers in children’s tonsils following live attenuated influenza vaccine. (ekstern lenke)
• Elisabeth Berg Fjelltveit; Rebecca Jane Cox; Bård Reiakvam Kittang et al. (2021). Lower antibiotic prescription rates in hospitalized COVID-19 patients than influenza patients, a prospective study. (ekstern lenke)
• Amit Bansal; Mai Chi Trieu; Kristin Greve-Isdahl Mohn et al. (2021). Safety, Immunogenicity, Efficacy and Effectiveness of Inactivated Influenza Vaccines in Healthy Pregnant Women and Children Under 5 Years: An Evidence-Based Clinical Review. (ekstern lenke)
• Shahinul Islam; Kristin Greve Isdahl Mohn; Florain Krammer et al. (2017). Influenza A haemagglutinin specific IgG responses in children and adults after seasonal trivalent live attenuated influenza vaccination. (ekstern lenke)
• Shahinul Islam; Fan Zhou; Sarah Larteley Lartey Jalloh et al. (2019). Functional immune response to influenza H1N1 in children and adults after live attenuated influenza virus vaccination. (ekstern lenke)
• Jannik Stemler; Lusine Yeghiazaryan; Christoph Stephan et al. (2024). Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B). (ekstern lenke)
• Elisabeth Berg Fjelltveit; Bjørn Blomberg; Kanika Kuwelker et al. (2022). Symptom Burden and Immune Dynamics 6 to 18 Months Following Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2): A Case-control Study. (ekstern lenke)
• Stella G. Muthuri; Sudhir Venkatesan; Puja R Myles et al. (2014). Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: A meta-analysis of individual participant data. (ekstern lenke)
• Abira Paramsothy; Sarah Larteley Lartey Jalloh; Richard Allan Davies et al. (2021). Humoral and cellular immune responses in critically ill influenza A/H1N1-infected patients. (ekstern lenke)
• Amit Bansal; Mai Chi Trieu; Kristin Greve-Isdahl Mohn et al. (2023). Risk assessment and antibody responses to SARS-CoV-2 in healthcare workers. (ekstern lenke)
• Kristin Greve Isdahl Mohn; Karl Albert Brokstad; Shahinul Islam et al. (2020). Early Induction of Cross-Reactive CD8+ T-Cell Responses in Tonsils After Live-Attenuated Influenza Vaccination in Children. (ekstern lenke)
• Abdullah Sami Madhun; Per Espen Akselsen; Haakon Sjursen et al. (2010). An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers. (ekstern lenke)
• Kanika Kuwelker; Fan Zhou; Bjørn Blomberg et al. (2021). Attack rates amongst household members of outpatients with confirmed COVID-19 in Bergen, Norway: A case-ascertained study. (ekstern lenke)
• Fan Zhou; Juha Vahokoski; Siri Øyen et al. (2024). Impact of ageing on homologous and human-coronavirus-reactive antibodies after SARS-CoV-2 vaccination or infection. (ekstern lenke)
• Kristin Greve Isdahl Mohn; Karl Albert Brokstad; Rishi Pathirana et al. (2016). Live attenuated influenza vaccine in children induces b-cell responses in tonsils. (ekstern lenke)
• Kristin Greve-Isdahl Mohn; Geir Bredholt; Fan Zhou et al. (2022). Durable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patients. (ekstern lenke)
• Kristin Greve Isdahl Mohn; Geir Bredholt; Karl Albert Brokstad et al. (2015). Longevity of B-cell and T-cell responses after live attenuated influenza vaccination in children. (ekstern lenke)
• Stella G. Muthuri; Sudhir Venkatesan; Puja R. Myles et al. (2016). Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: An individual participant data meta-analysis. (ekstern lenke)
• Lukas Anders Kryger Hoen; Sarah Larteley Lartey Jalloh; Fan Zhou et al. (2024). Impact of Pre-Existing Immunity and Age on Antibody Responses to Live Attenuated Influenza Vaccine. (ekstern lenke)
• Bjørn Blomberg; Kristin Greve-Isdahl Mohn; Karl Albert Brokstad et al. (2021). Long COVID in a prospective cohort of home-isolated patients. (ekstern lenke)
• Nina Urke Ertesvåg; Sunniva Todnem Sakkestad; Fan Zhou et al. (2022). Persistent Fever and Positive PCR 90 Days Post-SARS-CoV-2 Infection in a Rituximab-Treated Patient: A Case of Late Antiviral Treatment. (ekstern lenke)
• Kristin Greve Isdahl Mohn; Fan Zhou; Karl Albert Brokstad et al. (2017). Boosting of cross-reactive and protection-associated T cells in children after live attenuated influenza vaccination. (ekstern lenke)
• Sarah Larteley Lartey Jalloh; Fan Zhou; Karl Albert Brokstad et al. (2020). Live-attenuated influenza vaccine induces tonsillar follicular T helper cell responses that correlate with antibody induction. (ekstern lenke)
• Jorge Jacob; Tor Biering-Sørensen; Lars Holger Ehlers et al. (2023). Cost-Effectiveness of Vaccination of Older Adults with an MF59^®-Adjuvanted Quadrivalent Influenza Vaccine Compared to Standard-Dose and High-Dose Vaccines in Denmark, Norway, and Sweden. (ekstern lenke)

Konferanseforedrag

• Amit Bansal; Mai Chi Trieu; Anders Madsen et al. (2020). Low infection and seroconversion rates in frontline healthcare workers during the peak of the Coronavirus disease 2019 pandemic in Bergen, Norway. (ekstern lenke)
• Amit Bansal; Mai Chi Trieu; Anders Madsen et al. (2020). SARS-COV-2-Specific neutralising antibody responses in Norwegian healthcare workers after the first wave of COVID-19 pandemic: a prospective cohort study. (ekstern lenke)
• Amit Bansal; Mai Chi Trieu; Anders Madsen et al. (2020). Antibody responses to SARS-CoV-2 virus in Norwegian health-care workers: an observational prospective cohort study. (ekstern lenke)
• Kristin Greve Isdahl Mohn; Rebecca Jane Cox; Fan Zhou et al. (2015). Cellular immune responses after live attenuated influenza vaccination in children, a clinical trial.. (ekstern lenke)

Medieintervju

• Rebecca Jane Cox; Kristin Greve Isdahl Mohn (2019). Dette appa­ratet kan på 15 minutter finne ut om du har influ­ensa. (ekstern lenke)
• Oddgeir Øystese; Kristin Greve Isdahl Mohn; Rebecca Jane Cox (2014). Behandling med Tamiflu reduserte mortaliteten under Pandemien i 2009. (ekstern lenke)
• Klaus Holthe; Gunnveig Grødeland; Rebecca Jane Cox et al. (2022). Ny vaksinestudie: – Svært viktig. (ekstern lenke)
• Ørjan Olsvik; Sven Arne Buggelund; Kristin Greve Isdahl Mohn et al. (2020). Harvard-professor om coronvaviruset: Tror over 40 prosent vil bli smittet. (ekstern lenke)

Tidsskriftomtale

• Kristin Greve Isdahl Mohn (2015). Dyptgående og informativt om vaksiner Bok anmeldelse: Vaksiner En forbannet velsignelse av Bjarne Bjorvatn. (ekstern lenke)

Forelesning

• Kristin Greve Isdahl Mohn; Rebecca Jane Cox (2015). Ytringsfrihet. (ekstern lenke)
• Kristin Greve Isdahl Mohn (2017). Vaksinemotstand på liv og død?. (ekstern lenke)
• Kristin Greve-Isdahl Mohn (2022). Pandemihåndtering i Norge. (ekstern lenke)
• Kristin Greve-Isdahl Mohn (2018). Influensavaksine, hva er det, og hvorfor bør vi ta det?. (ekstern lenke)
• Kristin Greve-Isdahl Mohn (2021). Covid-19 Immunitet og vaksinerespons. (ekstern lenke)
• Kristin Greve-Isdahl Mohn (2021). klinisk bilde ved Covid sykdom, hvorfor er det så ulikt?. (ekstern lenke)
• Kristin Greve-Isdahl Mohn (2022). Influensa og vaksiner. (ekstern lenke)
• Kristin Greve-Isdahl Mohn (2021). Vaksiner, smarte, små stikk!. (ekstern lenke)
• Kristin Greve Isdahl Mohn (2017). Virale epidemier, historiske og fremtidige trusler. (ekstern lenke)

Fremhevet artikkel i media

• Kristin Greve Isdahl Mohn; Rebecca Jane Cox (2015). Sølje Bergman er farligere for barn enn vaksiner. (ekstern lenke)
• Gunnveig Grødeland; Rebecca Jane Cox; Kristin Greve-Isdahl Mohn et al. (2024). Hvor bekymret skal vi være for fugleinfluensa? Ganske.. (ekstern lenke)
• Rebecca Jane Cox; Kristin Greve Isdahl Mohn (2017). Gravide – se opp for fake news!. (ekstern lenke)
• Rebecca Jane Cox; Kristin Greve Isdahl Mohn (2017). Nok tro og folelser na. (ekstern lenke)
• Nina Ertesvåg; Kristin Greve Isdahl Mohn; Rebecca Jane Cox (2018). Få en influensafri jul!. (ekstern lenke)

Konferanseposter

• Lukas Anders Kryger Hoen; Sarah Larteley Lartey Jalloh; Kristin Greve-Isdahl Mohn et al. (2023). A Comparison of Humoral Responses Induced Following Live Attenuated Influenza Vaccination in Children and Adults. (ekstern lenke)
• Fan Zhou; Rishi Delan Pathirana; Sarah Larteley Lartey Jalloh et al. (2024). Phenotypic and functional changes of human follicular T helper cells over decades of life. (ekstern lenke)
• Fan Zhou; Rishi Delan Pathirana; Sarah Larteley Lartey Jalloh et al. (2016). Age related decline of T follicular helper cells in children and adults. (ekstern lenke)
• Fan Zhou; Steffen Aleksander Slettevoll; Sarah Larteley Lartey Jalloh et al. (2017). Live attenuated in+luenza vaccine elicits superior follicular T help cell and local antibody responses in children. (ekstern lenke)
• Fan Zhou; Rishi Delan Pathirana; Sarah Larteley Lartey Jalloh et al. (2015). Follicular helper T cell responses in children and adults after vaccination with seasonal 2013-14 live attenuated influenza vaccine. (ekstern lenke)
• Fan Zhou; Rishi Delan Pathirana; Sarah Larteley Lartey Jalloh et al. (2016). Follicular helper T cell responses in children and adults after vaccination with seasonal 2013-14 live attenuated influenza vaccine. (ekstern lenke)

Leserbrev

• Kristin Greve-Isdahl Mohn; Geir Bredholt; Therese Bredholt Onyango et al. (2023). SARS-CoV-2 infection induces long-lived B and T-cell responses up to 15 months post-infection, irrespective of disease severity. (ekstern lenke)

Vitenskapelig litteraturgjennomgang

• Kristin Greve Isdahl Mohn; Ingrid Smith; Haakon Sjursen et al. (2017). Immune responses after live attenuated influenza vaccination. (ekstern lenke)
• Reidar Kvåle; Nessar Ahmad Azrakhsh; Kristin Greve Isdahl Mohn et al. (2020). COVID-19 and venous thromboembolism - prophylaxis and treatment. (ekstern lenke)
• Kristin Greve Isdahl Mohn; Fan Zhou (2018). Clinical expectations for better influenza virus vaccines - perspectives from the young investigators' point of view. (ekstern lenke)

Deltakelse i radio eller TV

• Magnus Vollset; Ole Frithjof Norheim; Kristin Greve-Isdahl Mohn et al. (2021). UiB Innsikt: Bergens vaksineforskning – i går, i dag og i morgen. (ekstern lenke)

Doktorgradsavhandling

• Kristin Greve Isdahl Mohn; Rebecca Jane Cox (2016). Immune response to influenza after vaccination and infection. (ekstern lenke)

Fagartikkel

• Haakon Sjursen; Kristine Livsdatter Aukland Talhaug; Kristin Greve Isdahl Mohn et al. (2018). Immunrespons etter levende svekket influensavksine. (ekstern lenke)

Populærvitenskapelig artikkel

• Elisabeth Berg Fjelltveit; Anders Madsen; Rebecca Jane Cox et al. (2018). Pandemivaksinen i 2009-en forberedelse til neste influensapandemi. (ekstern lenke)

Se en fullstendig oversikt over publikasjoner i NVA.